SynthesisEuropean journal of neurology2026
Efficacy, IHS Guideline Adherence, and Methodological Quality of Noninvasive Neuromodulation Clinical Trials in Migraine and Cluster Headache: A Systematic Review.
Synthesis in European journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNoninvasive neuromodulation has emerged as a promising approach for acute and preventive treatment of migraine and cluster headache. This systematic review evaluates how noninvasive neuromodulation trials align with guidelines by the International Headache Society (IHS), their efficacy on IHS-recommended outcomes, and the robustness of the supporting evidence.
methodsA systematic search of MEDLINE, Embase, ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform was conducted for clinical trials published between January 1990 and October 2024. Studies evaluating noninvasive neuromodulation for acute or preventive treatment of migraine or cluster headache were included based on predefined eligibility criteria. Data were analyzed with respect to study design, adherence to endpoints recommended by IHS, and efficacy of reported outcomes.
resultsSeventy trials met inclusion criteria, covering modalities such as noninvasive vagus nerve stimulation (nVNS), external trigeminal nerve stimulation (e-TNS), single- and repetitive transcranial magnetic stimulation (sTMS, rTMS), and remote electrical neuromodulation (REN), among others. For migraine, acute treatment studies were mostly randomized, sham-controlled, and blinded, while preventive trials showed greater variability. Significant heterogeneity was noted in the use of IHS-recommended endpoints. For cluster headache, nVNS remains the only modality evaluated.
conclusionsNoninvasive neuromodulation holds potential for acute and preventive treatment of migraine and cluster headache. However, considerable variability exists in study design, outcomes, and adherence to IHS guidelines across trials. Additional robust, sham-controlled studies are needed to validate the clinical efficacy of these interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.